Not recruiting yet
Remote Robotic Surgery for Gynecologic Cancer: A Safety and Effectiveness Study
NCT07896720 · Women's Hospital School Of Medicine Zhejiang University · Updated 27 Oct 2026
- What is being tested
- MP2000 Thoracoabdominal Endoscopic Surgical System
- For
- Endometrial Cancer; Cervical Cancer (Early Detection)
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 80 years. About 92 people. The full rules are on the registry page.
- Where
- Not stated
- When
- Starts or started 1 Oct 2026, ends 1 Sept 2029. Registered 27 Oct 2026.
- Results
- None posted yet.
In the researchers' words
This investigator-initiated, multicenter, single-blind, randomized controlled clinical study is designed to evaluate the safety and effectiveness of the MP2000 thoracoabdominal endoscopic surgical system (Shenzhen Jingfeng Medical Technology Co., Ltd.) when used for remote robotic surgery in patients with gynecologic malignancies. By comparing remote robotic surgery with local robotic surgery, the study will assess clinical outcomes including postoperative recovery, the incidence of complications, and the length of hospital stay, thereby providing clinical evidence on the safety and efficacy of remote robotic surgery versus conventional local robotic surgery.